Last updated: August 20, 2023
Sponsor: Affiliated Hospital of Nantong University
Overall Status: Active - Recruiting
Phase
1/2
Condition
Brain Function
Treatment
Normal saline
acetaminophen mannitol
Clinical Study ID
NCT06004687
zhhszjjh
Ages 16-88 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients undergoing gastrointestinal tumor surgery
- American Society of Anesthesiologists(ASA)≤Ⅲ
Exclusion
Exclusion Criteria:
- History of severe adverse reactions to oral acetaminophen
- Dysfunction of heart, liver, kidney and other important organs
- History of chronic pain
- Oral non-steroidal or opioid drugs
- Patients who do not accept clinical trials
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Normal saline
Phase: 1/2
Study Start date:
July 26, 2023
Estimated Completion Date:
December 30, 2024
Study Description
Connect with a study center
Affiliated Hospital of nantong University
Nantong, Jiangsu 226001
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.